$400 Billion Pharma Megadeal? Jefferies Calls Potential AstraZeneca-Bristol Myers Merger A "Head Scratcher"
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-08-03 21:45 UTC+10:00
Section: General
Factuality Score: 95
Opinion Category: Neutral
Topics: Business, Economy & Finance, Financial Markets, World News, Business & Economy
--------------------------------------------------------------------
Snippet:
The Financial Times reported overnight that AstraZeneca has explored acquiring Bristol Myers Squibb in a potential megadeal that would create one of the world's largest drugmakers, with a combined market capitalization of nearly $400 billion.
--------------------------------------------------------------------